These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3254104)

  • 1. Interference by pro-apolipoprotein A-I in apolipoprotein E phenotyping using chemical precipitation procedures.
    Rawlings AV; Deegan T
    Ann Clin Biochem; 1988 Nov; 25 ( Pt 6)():638-44. PubMed ID: 3254104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein E Bethesda. Isolation and partial characterization of a variant of human apolipoprotein E isolated from very low density lipoproteins.
    Ghiselli G; Gregg RE; Brewer HB
    Biochim Biophys Acta; 1984 Jul; 794(2):333-9. PubMed ID: 6428460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An erroneous apolipoprotein E-3 band in high density lipoprotein fractions.
    Rawlings AV; Deegan T
    J Inherit Metab Dis; 1988; 11 Suppl 2():135-8. PubMed ID: 3141692
    [No Abstract]   [Full Text] [Related]  

  • 4. A rapid micromethod for apolipoprotein E phenotyping directly in serum.
    Havekes LM; de Knijff P; Beisiegel U; Havinga J; Smit M; Klasen E
    J Lipid Res; 1987 Apr; 28(4):455-63. PubMed ID: 3585179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein EBethesda: a new variant of apolipoprotein E associated with type III hyperlipoproteinemia.
    Gregg RE; Ghiselli G; Brewer HB
    J Clin Endocrinol Metab; 1983 Nov; 57(5):969-74. PubMed ID: 6578216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of apolipoprotein E isoforms between very low and high density lipoproteins of normal subjects and hyperlipidemic patients with special reference to type III hyperlipidemia.
    Holmquist L
    Acta Med Scand; 1984; 215(2):113-20. PubMed ID: 6702490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simple precipitation-based method for the screening of type III hyperlipoproteinemia.
    Nauck M; Glatt L; März W; Feussner G; Wieland H
    Clin Chem; 1999 Jun; 45(6 Pt 1):909-11. PubMed ID: 10352005
    [No Abstract]   [Full Text] [Related]  

  • 8. A method for the identification of apolipoprotein E isoforms employing chemical precipitation and flat bed isoelectric focusing in agarose.
    Kane JW; Gowland E
    Ann Clin Biochem; 1986 Sep; 23 ( Pt 5)():509-13. PubMed ID: 3767285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of apolipoprotein E between free and A-II complexed forms in very-low- and high-density lipoproteins: functional implications.
    Borghini I; James RW; Blatter MC; Pometta D
    Biochim Biophys Acta; 1991 May; 1083(2):139-46. PubMed ID: 1903658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in vitro study of the pro-apolipoprotein A-I to apolipoprotein A-I converting activity between normal and Tangier plasma.
    Edelstein C; Gordon JI; Vergani CA; Catapano AL; Pietrini V; Scanu AM
    J Clin Invest; 1984 Sep; 74(3):1098-103. PubMed ID: 6432845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Remnant disease associated with apoprotein E1; clinical importance of apoprotein E (apo E) phenotypes].
    Borghini I; James RW; Pometta D
    Schweiz Med Wochenschr; 1989 Dec; 119(50):1821-4. PubMed ID: 2609136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoelectric focusing of apolipoproteins in immobilized pH gradients: improved determination of apolipoprotein E phenotypes.
    Baumstark MW; Berg A; Halle M; Keul J
    Electrophoresis; 1988 Sep; 9(9):576-9. PubMed ID: 3243253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of different isolation procedures on high density lipoprotein subfractions obtained by isoelectric focusing.
    Luley CH; Puchois P; Kloer HU
    Clin Chim Acta; 1985 Mar; 146(2-3):185-93. PubMed ID: 3921289
    [No Abstract]   [Full Text] [Related]  

  • 14. Polymorphism of apolipoprotein E. I. Methodological aspects and diagnosis of hyperlipoproteinemia type III without ultracentrifugation.
    Utermann G; Albrecht G; Steinmetz A
    Clin Genet; 1978 Dec; 14(6):351-8. PubMed ID: 215358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a new structural variant of human apolipoprotein E, E2(Lys146 leads to Gln), in a type III hyperlipoproteinemic subject with the E3/2 phenotype.
    Rall SC; Weisgraber KH; Innerarity TL; Bersot TP; Mahley RW; Blum CB
    J Clin Invest; 1983 Oct; 72(4):1288-97. PubMed ID: 6313758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the protein composition of human serum very low density lipoproteins: demonstration of the beta 2-glycoprotein-I.
    Polz E; Kostner GM; Holasek A
    Hoppe Seylers Z Physiol Chem; 1979 Aug; 360(8):1061-7. PubMed ID: 229068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hyperlipoproteinemia type III with apolipoprotein E phenotype 2/2].
    Engst R
    Hautarzt; 1985 Nov; 36(11):629-34. PubMed ID: 4077508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electroblotting of Immobiline DryPlates applied to identification of human plasma apolipoprotein A-I.
    Holmquist L
    Electrophoresis; 1988 Sep; 9(9):511-3. PubMed ID: 3149578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High receptor binding affinity of lipoproteins in atypical dysbetalipoproteinemia (type III hyperlipoproteinemia).
    Chappell DA
    J Clin Invest; 1989 Dec; 84(6):1906-15. PubMed ID: 2556448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Distribution of the apolipoprotein-E and -E-complexes in lipoproteins of human serum with the apolipoprotein-E4/E3 phenotype].
    Hidaka H; Tozuka M; Yamauchi K; Sugano M; Nakabayashi T; Katsuyama T
    Rinsho Byori; 1997 Dec; 45(12):1172-6. PubMed ID: 9437899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.